Assyro AI

FDA Orange Book · active-ingredient family

Ethynodiol diacetate; mestranol

Ethynodiol diacetate; mestranol is approved in 2 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

Reference-listed drug:OVULEN · NDA 016029

2

Brand (NDA)

0

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · tablet

ProductApplicantApplicationTEApproved
OVULEN×2GD SEARLE LLCNDA 016029Approved Prior to Jan 1, 1982
OVULEN-28GD SEARLE LLCNDA 016705Approved Prior to Jan 1, 1982

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Ethynodiol diacetate; mestranol — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.